Amundi Asset Management US’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | $2.6M | Buy |
225,185
+2,009
| +0.9% | +$23.2K | ﹤0.01% | 1146 |
|
2020
Q4 | $2.16M | Buy |
223,176
+16,309
| +8% | +$157K | ﹤0.01% | 1121 |
|
2020
Q3 | $1.86M | Buy |
206,867
+59,928
| +41% | +$540K | ﹤0.01% | 1099 |
|
2020
Q2 | $1.81M | Buy |
146,939
+37,726
| +35% | +$465K | ﹤0.01% | 1085 |
|
2020
Q1 | $981K | Sell |
109,213
-18,126
| -14% | -$163K | ﹤0.01% | 1094 |
|
2019
Q4 | $1.25M | Buy |
127,339
+26,028
| +26% | +$255K | ﹤0.01% | 1195 |
|
2019
Q3 | $697K | Sell |
101,311
-4,400
| -4% | -$30.3K | ﹤0.01% | 1265 |
|
2019
Q2 | $976K | Buy |
105,711
+3,950
| +4% | +$36.5K | ﹤0.01% | 1236 |
|
2019
Q1 | $1.6M | Buy |
101,761
+9,571
| +10% | +$150K | ﹤0.01% | 1115 |
|
2018
Q4 | $1.42K | Buy |
92,190
+18,324
| +25% | +$282 | ﹤0.01% | 1086 |
|
2018
Q3 | $1.59M | Buy |
73,866
+1,369
| +2% | +$29.5K | ﹤0.01% | 1150 |
|
2018
Q2 | $1.76M | Buy |
72,497
+1,297
| +2% | +$31.6K | ﹤0.01% | 1147 |
|
2018
Q1 | $1.22M | Buy |
71,200
+12,158
| +21% | +$208K | ﹤0.01% | 1157 |
|
2017
Q4 | $1.12M | Buy |
+59,042
| New | +$1.12M | ﹤0.01% | 1187 |
|
2016
Q1 | – | Sell |
-354,962
| Closed | -$23.3M | – | 578 |
|
2015
Q4 | $23.3M | Sell |
354,962
-1,284,267
| -78% | -$84.3M | 0.09% | 196 |
|
2015
Q3 | $92.6M | Buy |
1,639,229
+483,763
| +42% | +$27.3M | 0.38% | 75 |
|
2015
Q2 | $68.3M | Buy |
1,155,466
+7,888
| +0.7% | +$466K | 0.25% | 113 |
|
2015
Q1 | $71.5M | Buy |
1,147,578
+111,857
| +11% | +$6.97M | 0.26% | 106 |
|
2014
Q4 | $59.6M | Buy |
1,035,721
+797,760
| +335% | +$45.9M | 0.22% | 125 |
|
2014
Q3 | $12.8M | Buy |
237,961
+10,196
| +4% | +$548K | 0.05% | 307 |
|
2014
Q2 | $11.9M | Buy |
227,765
+209,947
| +1,178% | +$11M | 0.05% | 315 |
|
2014
Q1 | $942K | Sell |
17,818
-60,600
| -77% | -$3.2M | ﹤0.01% | 581 |
|
2013
Q4 | $3.14M | Sell |
78,418
-772,960
| -91% | -$31M | 0.01% | 501 |
|
2013
Q3 | $32.2M | Buy |
851,378
+88,907
| +12% | +$3.36M | 0.13% | 186 |
|
2013
Q2 | $29.9M | Buy |
+762,471
| New | +$29.9M | 0.12% | 200 |
|